GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenith Capital Corporation (TSXV:ZENI.P) » Definitions » 12-1 Month Momentum %

Zenith Capital (TSXV:ZENI.P) 12-1 Month Momentum % : N/A% (As of May. 29, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Zenith Capital 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-29), Zenith Capital's 12-1 Month Momentum % is N/A%.

The industry rank for Zenith Capital's 12-1 Month Momentum % or its related term are showing as below:

TSXV:ZENI.P's 12-1 Month Momentum % is not ranked *
in the Biotechnology industry.
Industry Median: -25
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Competitive Comparison of Zenith Capital's 12-1 Month Momentum %

For the Biotechnology subindustry, Zenith Capital's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenith Capital's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zenith Capital's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Zenith Capital's 12-1 Month Momentum % falls into.



Zenith Capital  (TSXV:ZENI.P) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenith Capital  (TSXV:ZENI.P) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Zenith Capital 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Zenith Capital's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenith Capital (TSXV:ZENI.P) Business Description

Traded in Other Exchanges
N/A
Address
2475 Queens Avenue, West Vancouver, BC, CAN, V7V 2Y9
Zenith Capital Corporation is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics for the treatment of cancer and other disorders with significant unmet medical needs. The company is developing various novel combinations of BET inhibitors with other targeted agents. The lead compound, ZEN-3694, is in clinical development for mCRPC in combination with androgen receptor inhibitor, XTANDI, with Astellas and Newsoara as collaborators; triple-negative breast cancer in combination with the PARP inhibitor TALZENNA with Pfizer as a collaborator; androgen receptor independent mCRPC in combination with immune checkpoint inhibitor KEYTRUDA and XTANDI with University of California, San Francisco as a collaborator.

Zenith Capital (TSXV:ZENI.P) Headlines

No Headlines